Entecavir

1 Drug classified under this active ingredient

Nucleoside Reverse Transcriptase Inhibitor. Entecavir 0.5 mg, 1 mg.
TABS.:30: Compens. liver dis.: Nucleoside naive pts.: 0.5 mg×1/d, with/without food. Lamivudine-refractory pts.: 1 mg ×1/d, without food. Decompens. liver dis.: 1 mg ×1/d, without food. For pts. with lamivudine-refractory hepatitis B, see lit.
Tmt. of chronic HBV infec. in adults with: Compens. liver dis.  and evidence of active viral replic. persist. elevated serum ALT levels and histolog. evidence of active inflam. and/ or fibrosis. Decompens.  liver dis. For both compens. and decompens. liver dis. , this indic.  is based on clinical trial data in nucleoside naive pts. with HBeAg positive and HBeAg negative HBV infec.  With respect to pts. with lamivudine-refract. hepatitis B.
C/I: Hypersens., lact.